Published in Oncology Business Week, February 26th, 2012
"We are looking forward to an exciting and eventful year as we advance development of our promising oncology compounds in multiple clinical trials," said Mr. Kriegsman. "Among the 2012 highlights, we...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.